CAS: 148218-14-8
| Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
|---|---|---|---|---|
 | Doxorubicin EP Impurity B HBr REF: 4Z-D-349CAS: 148218-14-8 | - - - | 2.415,00 €~20.058,00 € | Mar 04 Mar 25 |
 | 14-Bromo, 13-Deoxo, 13,13-Dimethoxy Daunorubicin Hydrobromide (>85%) REF: TR-A630405CAS: 148218-14-8 | >85% | 347,00 €~2.290,00 € | Ven 11 Apr 25 |
 | Doxorubicin Imp B HBr salt REF: 3D-AA145165CAS: 148218-14-8 | Min. 95% | Prezzo su richiesta | Lun 14 Apr 25 |
Doxorubicin EP Impurity B HBr
CAS:148218-14-8
Formula:
C29H34BrNO11·HBr
Colore e forma:
Red Solid
Peso molecolare:
652.50 80.91
Ref: 4Z-D-349
| 5mg | 2.415,00 € | ||
| 10mg | 4.066,00 € | ||
| 25mg | 7.454,00 € | ||
| 50mg | 12.197,00 € | ||
| 100mg | 20.058,00 € |
Consegna stimata in Stati Uniti, il Martedì 04 Marzo 2025
14-Bromo, 13-Deoxo, 13,13-Dimethoxy Daunorubicin Hydrobromide (>85%)
Prodotto ControllatoCAS:148218-14-8
Applications (8S,10S)-10-[(3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-(2-bromo-1,1-dimethoxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione, is the metabolite of Doxorubicin (D558000), which is a neoplasm inhibitor,and an antineoplastic. …
Formula:
C29H34BrNO11·BrH
Purezza:
>85%
Colore e forma:
Neat
Peso molecolare:
733.40
Ref: TR-A630405
| 10mg | 347,00 € | ||
| 100mg | 2.290,00 € |
Consegna stimata in Stati Uniti, il Venerdì 11 Aprile 2025
Doxorubicin Imp B HBr salt
CAS:148218-14-8
Doxorubicin Imp B HBr salt is a drug product that is custom synthesized for research …
Formula:
C29H34BrNO11BrH
Purezza:
Min. 95%
Peso molecolare:
733.4 g/mol
Ref: 3D-AA145165
| 2mg | 348,00 € | ||
| 5mg | 453,00 € | ||
| 10mg | 565,00 € | ||
| 25mg | 1.085,00 € |
Consegna stimata in Stati Uniti, il Lunedì 14 Aprile 2025
